Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Operating Leases (2019 - 2025)

vTv Therapeutics' Operating Leases history spans 7 years, with the latest figure at $125000.0 for Q1 2025.

  • For Q1 2025, Operating Leases changed 0.0% year-over-year to $125000.0; the TTM value through Mar 2025 reached $125000.0, changed 0.0%, while the annual FY2024 figure was $169000.0, 0.0% changed from the prior year.
  • Operating Leases for Q1 2025 was $125000.0 at vTv Therapeutics, down from $169000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $633000.0 in Q1 2021 and bottomed at $125000.0 in Q1 2024.
  • The 5-year median for Operating Leases is $338000.0 (2022), against an average of $349647.1.
  • The largest YoY upside for Operating Leases was 7.47% in 2023 against a maximum downside of 60.63% in 2023.
  • A 5-year view of Operating Leases shows it stood at $492000.0 in 2021, then crashed by 31.3% to $338000.0 in 2022, then crashed by 50.0% to $169000.0 in 2023, then changed by 0.0% to $169000.0 in 2024, then fell by 26.04% to $125000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Operating Leases are $125000.0 (Q1 2025), $169000.0 (Q4 2024), and $213000.0 (Q3 2024).